Blood Products Advisory Committee (BPAC)

The Blood Products Advisory Committee (BPAC) is a group of experts that advises the FDA on issues related to blood and blood components used for transfusions and medical treatments. They review scientific data, ensuring the safety, effectiveness, and proper use of blood products. Their recommendations help shape policies and guidelines to protect patients and improve blood safety. BPAC meetings are technical but aim to inform FDA decisions that impact public health globally.